News Release

2007-2008 Genzyme/ACMGF Clinical Genetics Fellowship In Biochemical Genetics award winner announced

$75,000 grant supports a national fellowship program to encourage training of clinicians in biochemical genetics

Grant and Award Announcement

American College of Medical Genetics and Genomics

Bethesda, MD – July 17, 2007 -- T. Andrew Burrow, MD of Cincinnati Children’s Hospital Medical Center was honored as the 2007-2008 recipient of the Genzyme/ACMGF Clinical Genetics Fellowship in Biochemical Genetics at the ACMG 2007 Annual Clinical Genetics Meeting in Nashville, TN.

The objective of this Fellowship Award is to support a national fellowship program to encourage the recruitment and training of clinicians in the field of clinical biochemical genetics and especially in the diagnosis, management and treatment of individuals with metabolic diseases. This award grants $75,000 per year.

“The American College of Medical Genetics Foundation supports the important research and educational programs of the ACMG. The Genzyme/ACMGF Clinical Genetics Fellowship in Biochemical Genetics award is especially important at this point in history as newborn screening programs are rapidly expanding in the United States and we need physicians trained in metabolic diseases and who are able to adapt to the evolution of therapeutic approaches to genetic diseases,” said R. Rodney Howell, MD, FACMG, president of the ACMGF.

###

Genzyme Corporation is a generous supporter of the American College of Medical Genetics Foundation and a member in good standing of its Partners in Science program. For more information about the program, go to: www.acmg.net/

About the American College of Medical Genetics Founded in 1991, the American College of Medical Genetics (www.acmg.net) advances the practice of medical genetics by providing education, resources and a voice for more than 1400 biochemical, clinical, cytogenetic, medical and molecular geneticists, genetic counselors and other health care professionals committed to the practice of medical genetics. ACMG’s activities include the development of laboratory and practice standards and guidelines, advocating for quality genetic services in health care and in public health, and promoting the development of methods to diagnose, treat and prevent genetic disease. Genetics in Medicine, published monthly, is the official ACMG peer-reviewed journal. ACMG’s website (www.acmg.net) offers a variety of resources including Policy Statements, Practice Guidelines, Educational Resources, and a Medical Geneticist Locator. The educational and public health programs of the American College of Medical Genetics are dependent upon charitable gifts from corporations, foundations, and individuals. The American College of Medical Genetics Foundation is a 501 (3)(c) not-for-profit organization dedicated to funding the College’s diverse efforts to translate genes into health.

About Genzyme

With many products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Visit www.genzyme.com.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.